Objective: One of the reasons of bacterial translocation (BT) is the complete or partial intestinal obstructions (PIO) of the gastrointestinal system. In this study, we aimed to investigate the effects of recombinant human Growth Hormone (rhGH) on BT in rats with partial intestinal obstruction (PIO).
The gastrointestinal system (GIS) as well as its functions of motility, absorption and secretion, has also immunologic, metabolic, endocrine functions and provides a mucosal defense barrier against translocation of bacteria/toxins from gut lumen into circulation and extra intestinal tissues (1) . Bacterial translocation (BT) is defi ned as the passage of viable bacteria from the gastrointestinal tract through the epithelial mucosa. Intestinal bacterial overgrowth, intestinal hypomotility and increased mucosal permeability, immunodefi ciencies are mechanisms suggested to increase BT (2, 3) .
Partial intestinal obstructions (PIO) induce intestinal bacterial overgrowth and subsequently promote translocation (4) . In the complete and PIO, microorganisms remain in close and longterm contact with the mucosa because of an impaired peristalsis and decreased amount of mucus. In these patients, the number of endogenous microorganisms increases besides intra-luminal stasis and the fl uid accumulation (5, 6) . Catabolic events and gastrointestinal dysfunction leads to the passage of the bacteria fi rst in mesenteric lymph ganglions (MLGs) and then to other tissues and organs by increasing the mucosal permeability (12, 2) .
Various trophic factors are tried and found effective in order to protect the integrity of GIS mucosa, at the same time, pointed that they decreased BT as well (2, (7) (8) (9) (10) . Although protective effects of GH have been reported in various studies of impairment of the gastrointestinal mucosa, including stress, sepsis, ischemia and subsequent reperfusion, the precise mechanisms of GI protection of GH are still unclear (11) (12) (13) (14) (15) .
The aim of the present study was to evaluate the effects of subcutaneously administered GH on bacterial translocation (BT) in rats with partial intestinal obstruction.
Material and method
The study was conducted in the Experimental Laboratory at Selcuk University, Medical Faculty. All procedures were performed according to the Guide for the Care and Use of Laboratory Animals. All protocols were approved by the Institutional Animal Care and Use Committee of the University and followed the institutional guidelines for the care and use of laboratory animals. Experiments were performed on 48 Wistar Albino adult male rats weighted 250-300 grams. The animals were housed in wire mesh cages, at normal room temperature, and a 12-hour light/dark. The animals were fasted for 8 hours before and during experiment, and received serum physiologic (SF) of 100 ml/kg/day via subcutane-ous route in the morning and evening for replacement. The rats were randomly divided into the 4 groups: Group I: Sham-operated (SO) (n = 12), Group II control PIO (n = 12), Group III: PIO with rhGH treatment for 5 days (n = 12), Group IV: PIO with rhGH treatment 5 days before PIO and 5 days after PIO (a total of 10 days) (n = 12). In the groups III and IV, the effects of 5 and 10 days administered rhGH were examined.
Surgical procedures
All procedures were performed under ether anesthesia applied 30 min prior to the experiment. The middle laparotomy was performed under sterile conditions. PIO was made with placement of a 8F nutrition catheter 5 cm proximal of ileocecal valve to the anti-mesenteric edge of the bowel and ligation together with the bowel, using a 4/0 atraumatic silk. After the removal of the catheter, the passage from the proximal of the stenosis area to the distal bowel was controlled. In the Sham group, 5 minutes after the formation of partial intestinal obstruction, both catheter and silk were removed.
The rats in the group III received rhGH (16 IU/ml of Genotropin, 3 IU/mg of specifi c activity, 1 ml of Kabi Pharmacia,16 IU of Recombinant somatotropin, 2.0 mg of aminoacetic acid, 41 mg mannitol, 0.29 mg of sodium dihydrogen phosphate, 0.28 mg of disodium phosphate, 3.0 mg of m-cresol, 1 ml. of water for injection, 1.15 ml of the volume of the solution) between 08.00 AM and 08.00 PM at a dose of 1.0 mg/kg/day subcutaneously for 5 days, immediately after the operation. In the group IV, rhGH started 5 days before PIO and continued 5 days after ligation at the same dose (a total of 10 days). All groups underwent reoperation on the 5 th day after PIO. Blood, intestinal fl uid, hepatic and mesentery lymph ganglions samples were obtained for biochemical, immunological, microbiological and histopathological analysis. Hepatic tissue and MLGs were squeezed and cultured. Culture was performed on eosin-methylene-blue (EMB), bloody medium and Saboroud-dextrose medium. Serum and intestinal fl uid IgA were measured using radial immunodiffusion method.
Histological examination of intestinal mucosa
Small intestinal specimens were taken 5 cm proximal from ligation and from ascending colon. Small and large intestinal specimens (6 samples per animal) were fi xed in formaldehyde, dehydrated with alcohol and embedded in paraffi n, then cut in 5μm sections and stained with hematoxylin eosin and Periodic acid-Schiff reaction (PAS). The specimens were assessed under a light microscope by the same experienced pathologist. Length and depth calculations of the intestinal villous and crypts were performed with an eyepiece micrometer under the light microscope (BH-2 Olympus), micrometer calibration was done for 40 magnitude objective. The calculation of Goblet cells were done on PAS stained slides by counting the total number of purple stained cells which easily can be distinguished from other enterocytes lined on villous and crypts. For evaluation of length, depth's and goblet number, measurements were done as repeating every sample for six distinct times, then taking the arithmetic mean of this six for student's-T test statistical analysis. To make more open this "six" returns; for each animal (n = 12x4 = 48) six slide was prepared (total 288 slides) and for each slide six separated microscopic fi elds (1728) was calculated. All photomicrographs were taken under the light microscope with image analysis software equipment attached (Olympus Application Software DP-2BSW)
Statistical analysis
When evaluating the results of the study, NCSS (Number Cruncher Statistical System) 2007&PASS 2008 Statistical Software (Utah, USA) was used for the statistical analysis. KruskalWallis test was used to compare the quantitative data between the groups and the Mann Whitney U test was used to determine the group that led to the difference. For the comparison of the parameter within the group, Wilcoxon sign test was used. The Pearson Chi-Square test was used for the comparison of qualitative data. The signifi cance level was considered as p < 0.05.
Results

Intraoperative results
In the relaparotomy of the rats of PIO group, it was observed that the small intestine at the proximal of the ligation was largely dilated, there was intra-luminal fl uid sequestration and edemous wall, and there were no bleeding and necrosis. The ligation did not completely close the intestinal lumen and the diameter of the colon was normal.
Serological results
A statistically signifi cant difference was found between the groups in terms of the levels of serum IgA. The levels of serum IgA were signifi cantly higher in the Group IV compared to the Group I, Group II and Group III (p < 0.05, p < 0.01). The levels of serum IgA were signifi cantly lower in the Group II than in Groups I and III (p < 0.01). No statistically signifi cant difference was found between the levels of serum IgA in the Group I and Group III (p > 0.05) (Fig. 1) . The IgA levels of intestinal fl uid were signifi cantly higher in the Group IV than in Group I, II and III (p < 0.01). The Group III n=12
Group IV n=12
Group I n=12 IgA levels of intestinal fl uid were not statistically different between other groups (p > 0.05). In the Group II, III and IV the IgA levels obtained from the intestinal fl uid were signifi cantly higher than serum IgA levels (p < 0.01, p < 0.05).
Histopathological results
In the Sham group, the histopathological fi ndings obtained from small intestine ( Fig. 2A ) and colon were normal, the intestinal villus lengths and the numbers of small intestinal and colonic goblet cells were greater than in other groups (p < 0.01). In the Group II, it was observed that the villus length in the small intestine was statistically shorter than in the Groups I, III and IV (p < 0.01) (Fig. 2B) . In addition, it was found that the crypt depths of colon were normal. It was seen that the goblet cells in the group III (Fig. 2C) were empty and their secretions were released into the lumen. The short length of the villi and the reduced number of goblet cells were statistically signifi cant only in the rats of the Group II (p < 0.01). In the group IV (Fig. 2D) , an increased number of emptied small intestinal goblet cells and lymphocyte cell infi ltration in small intestine and colon was observed. In this group, the number of intestinal and colonic goblet cells and the villus length and crypt depths were statistically signifi cantly higher compared to the Groups II and III (p < 0.001).
Microbiological results
In the fi rst group, 3/12 rats (33.3 %) showed growth in MLGs and did not show growth in the blood and hepatic cultures. In the second group, 100 % of the rats showed growth in MLGs, 5/12 rats (41.6 %) showed growth in the blood culture and 7/12 (50.8 %) showed growth in the hepatic cultures. In the third group, 9/12 rats (75 %) showed growth in MLGs, 4/12 (33.3 %) showed growth in blood cultures and 5/12 (41.6 %) showed growth in hepatic cultures. In the fourth group, 7/12 rats (50.8 %) showed growth in MLGs, 2/12 (16.6 %) showed growth in blood culture and 2/12 (16.6 %) showed growth in hepatic culture. In the blood cultures, no statistically signifi cant difference was found between the groups in terms of growth (p > 0.05). The growth observed in MLGs and hepatic cultures of the rats in the Group II was signifi cantly higher compared to other groups (p < 0.01, p < 0.05) (Fig. 3) . In all groups, aerobic bacteria were more commonly isolated: E. coli (12, 48 %), Proteus (5, 76 %), Enteroccocus (2, 88 %). Anaerobic pathogens as Peptostreptococcus (3, 83 %) were rarely isolated (Fig. 3) .
Discussion
Pathologic conditions such as necrotizing enterocolitis, sepsis, stress, burns, obstructive jaundice, and trauma compromised the integrity of the intestinal mucosal barrier (1, 2, 5, 7, 8, 13, 14, 16) . Intestinal mucosa plays an important role in the prevention of BT. The partial obstruction impairs intestinal motility, absorption and secretion and leads to delay in the bacterial elimination, which induces intestinal bacterial overgrowth and promotes BT. BT is suspected as an important reason in the pathogenesis of the sepsis and multi organ failure (3) (4) (5) (6) . In a study conducted on the rats, a BT was seen at 60 % in the fi rst 6 hours in the rats underwent proximal complete ligation of small intestine and at 40 % in the MLG in the rats with distal ligation of small intestine. In the same study, after 24-48 hours, BT was not only limited to MLGs but spread to the liver, spleen, and blood stream. The isolation of intestinal bacteria in normally sterile, MLGs is considered as a direct evidence of BT. Moreover, after 48 hours, a destruction of the villus structures and epithelial cells were observed (4). In our study, on 5th day after PIO the bacterial growth in MLGs, liver and blood cultures in the Group II was 100 %, 50.8 %, 41.6 % respectively. No signifi cant difference between the groups was found in terms of the growth observed in blood cultures. Histopathological examination of small intestine in the Group II rats demonstrated a destruction/shortening of the villus heights and decrease of small intestinal goblet cell numbers. The similar results were reported in human studies (6) . The large presence of bacterial translocation in MLG and other tissues is attributed to the fasting and to the long-term partial obstruction. In the fasting state, mucosal permeability for macromolecules increases and the atrophy of intestinal mucosa, a shortening of villus height and a decrease in the growth of epithelial cells and the activity of intestinal enzyme occurred (10) . In our Sham group, the BT of 33.3 % in MLG might be attributed to the fasting state. It was found that trophic factors such as IGF-1, rhGH, glutamine, IgA were effective in the protection of the intestinal functions and structure as well as the prevention of BT (13, 17, 20, 23) . GH enhances Th1 cytokine activity, stimulates immunoglobulin secretion of B cells, NK cell activity, phagocytosis, and killing capacity of neutrophils and macrophages (18, 20, 21) . Prieto et al (23) demonstrated that rhGH could promote the release and chemotaxis of neutrophils, minimize the spread of bacteria and attenuate bacteria/endotoxin translocation, and then reduce plasma endotoxin level.
Experimental studies showed that, during conditions such as intestinal obstruction, obstructive jaundice, burning, trauma, fasting and chemotherapy, serum IgA levels were reduced, the mucosal resistance was decreased and BT occurred (12) (13) (14) (15) (16) (17) 20) . The main immunoglobulin on mucosal surfaces is IgA. IgA2 accounts for 15-20 % of the total IgA and it is more abundant in the secretions. IgA neutralizes the bacteria by adhesion. This occurs in the mucus. The complex of "mucus-IgA-bacteria" is eliminated with peristaltic movements of the bowel. In the rabbits, it was shown that intestinal IgA had a protective effect in the neonatal bowelderived sepsis (22) . Secretory IgA on intestinal mucosal surfaces inhibits bacterial adherence to mucosal surfaces and appears to be more effective in reducing the spread of bacteria penetrated intestinal mucosa than inhibiting the initial translocation of bacteria across the intestinal mucosa to the MLGs. A number of studies revealed that GH had important role in regulation of humoral and cellular immune functions (9, 17, (22) (23) (24) (25) . The administration of rhGH increases the level of total serum and intestinal fl uid IgA and thereby, the bacterial growth may be inhibited and bacterial translocation may be reduced. In our study, it was demonstrated that administration of rhGH increased the total level of IgA in serum and in the intestinal fl uid, and that it provided a better prevention of bacterial translocation depending on the time.
Recent studies demonstrated that rhGH might protect the damage of the intestinal mucosa by inhibiting apoptosis of intestinal mucosa cells and increasing of IGF-1 levels (11, 15, 17, 25) . The biological effects of GH are indirectly mediated by IGF-1. IGF-1 can prevent intestinal atrophy in septic rats and protect the integrity of intestinal structure (11, 12, 13, 18, 21) . Gary et al reported that the development of bacterial translocation is inversely correlated with serum IGF-1 levels and treatment with IGF-1 decreased enterocyte apoptosis (19) . Thus, GH improves the impairment of the intestinal mucosa and maintains the structure and function of the intestinal mucosal barrier (12) (13) (14) 20) .
Studies have demonstrated increased villus height and crypt depth, when rats were given rhGH alone or in combination with glutamine (10, 13, 15, 17, 23) . In agreement with these studies, we determined a signifi cant increase of the villus height and the numbers of small intestinal and colonic goblet cell after 10 days of rhGH (1 mg/kg/day) administration, also increased levels of serum and intestinal fl uid IgA were observed. However, it was observed that an administration of rhGH during 10 days led to a decrease by 50 % in the BT seen in MLGs. In the cultures, the most abundantly growing bacteria were E. coli. As E. coli is present in the bowel, it is thought that it leads to BT more than other microorganisms.
Consequently, the administration of rhGH to the rats for at least 10 days decreases intestinal damage and subsequent BT, with its protective effects in maintaining the integrity of intestinal mucosa and the levels of IgA. It was thought that these effects might be mediated by IGF-1 and rhGH receptors located in the intestine. rhGH could accelerate the clearance of bacteria, minimize the spread of bacteria to blood and decrease plasma endotoxin and proinfl ammatory cytokines levels. We suggested that it would be very useful to perform studies for investigation of rhGH effects on BT in humans.
